generic pharmaceuticals articles & resources on Made-in-China.com

Mylan Today Announced That Subsidiary Mylan Pharmaceuticals and Partner,Banner Pharmacaps

Dec 19, 2013

Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. and partner, Banner Pharmacaps Inc. (a wholly-owned subsidiary of Patheon Inc.), have entered into a settlement and license agreement with Eisai Inc. ...

Tags: Mylan, Targretin Suit, Treatment of Cutaneous Manifestations

Mylan Pharmaceuticals Has Introduced Voriconazole for Oral Suspension

Oct 8, 2013

Mylan Pharmaceuticals, a subsidiary of Mylan, has introduced Voriconazole for oral suspension, 40 mg/mL, which is the first generic version of Pfizer's VFEND for oral suspension. The US Food and Drug Administration (FDA) has granted a ...

Tags: Mylan, Antifungal Drug

Abbott Completed Its Acquisition of Idev Technologies

Aug 26, 2013

Abbott has completed its acquisition of Idev Technologies, a privately held firm that manufactures next-generation medical devices for use by interventional radiologists, vascular surgeons and cardiologists, for $310m. Abbott believes ...

Tags: Abbott, Idev Technologies

Amerigen Collaborated to Develop a Number of Specialty Generic Products

Aug 2, 2013

Amerigen Pharmaceuticals, a group of companies engaged in all phases of the generic pharmaceutical business, has collaborated with Forest Laboratories to develop a number of specialty generic products. The collaboration will leverage ...

Tags: Amerigen Partners, Generic Product

Mylan Pharmaceuticals Has Introduced Norethindrone for The Prevention of Pregnancy in US

Jul 18, 2013

Mylan Pharmaceuticals has introduced Norethindrone Tablets USP, 0.35mg, which is the generic version of Watson Laboratories' (now Actavis) Nor-Q.D. tablets, 0.35mg for 28-day cycle, for the prevention of pregnancy in the US. The ...

Tags: Generic Contraceptive Pill, Mylan

Tris Pharma Has Launched Dextroamphetamine Sulfate Oral Solution

Jul 12, 2013

Specialty pharmaceutical company Tris Pharma's generic pharmaceuticals business has launched Dextroamphetamine Sulfate Oral Solution to treat attention deficit disorder with hyperactivity (ADHD) and narcolepsy in the US. Available through ...

Tags: Tris Pharma, Medicine

Synergistic Collaboration in Brazil to Expand Their Respective Businessess in The Country

Apr 22, 2013

Daiichi Sankyo Company and Ranbaxy Laboratories have announced synergistic collaboration in Brazil to expand their respective businessess in the country. As part of the synergy, the companies will launch hybrid business model. Ranbaxy ...

Tags: Daiichi Sankyo Company, Medicine

Us Fda Approves Aurobindo Pharma's Nafcillin Injections

Dec 31, 2012

Aurobindo Pharma has secured approval from the US FDA to manufacture and market nafcillin for injection USP, packed in 1g and 2g bottles as well as nafcillin for injection USP 10g bottle pharmacy bulk package. Nafcillin, is a sterile ...

Tags: Aurobindo Pharma, market nafcillin, injection USP, pharmacy bulk package

Actavis Group Gained FDA Approval for Ropinirole Extended-Release Tablets

Dec 7, 2012

Actavis Group, a generic pharmaceuticals company, has gained FDA approval for Ropinirole extended-release tablets, 2mg, 4mg, 6mg, 8mg and 12mg. The company has started distribution of the generic version of GlaxoSmithKline's Requip XL. ...

Tags: Actavis Group, ropinirole extended-release tablets

Watson Laboratories Won FDA Abbreviated New Drug Application Approval

Dec 5, 2012

Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has won FDA abbreviated new drug application approval for Diclofenac Sodium and Misoprostol Delayed-Release Tablets. The company plans to launch Diclofenac Sodium and ...

Tags: Watson Laboratories

Watson Laboratories Gained FDA ANDA Approval for Next Choice ONE DOSE

Dec 5, 2012

Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has gained FDA abbreviated new drug application (ANDA) approval for Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5mg). The Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5mg) ...

Tags: ONE DOSE, levonorgestrel tablet, Watson Pharmaceuticals

Watson Laboratories Received FDA Approval for Its ANDA of Trospium Chloride Capsules

Dec 4, 2012

Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has received FDA approval for its abbreviated new drug application (ANDA) of Trospium Chloride Extended-release Capsules. Watson anticipates beginning the shipment of the ...

Tags: FDA, Trospium Chloride Extended-release Capsules, pharmaceutical product

EC Approval for Its Pending Acquisition of The Privately Held Actavis Group

Dec 4, 2012

US-based global specialty pharmaceutical company, Watson Pharmaceuticals has received European Commission's (EC) approval for its pending acquisition of the privately held Actavis Group. Watson president and CEO Paul Bisaro said,"Approval ...

Tags: Watson Pharmaceuticals, generic pharmaceuticals, pharmaceutical products

GSK Has Announced an Agreement with Aspen Global to Divest Majority of Classic Brands

Nov 30, 2012

GlaxoSmithKline (GSK) has announced an agreement with Aspen Global to divest majority of Classic Brands, including 25 non-promoted and genericised products in Australia for approximately £172m in cash. The divested brands include ...

Tags: Valtrex, Lamictal, Timentin, Amoxil, branded and generic pharmaceuticals

Mylan Pharmaceuticals Has Received Final FDA Approval for Its ANDA

Nov 29, 2012

Mylan Pharmaceuticals has received final FDA approval for its abbreviated new drug application (ANDA) for Lithium Carbonate Extended-release tablets USP, 300mg. Mylan has announced immediate shipment of the generic version of Noven ...

Tags: new drug, Lithium Carbonate Extended-release tablets USP, manic episodes

generic pharmaceuticals

Related Products